The final results verify conclusions drawn by Bagli et al. [1], who executed a examine that integrated 10 patients diagnosed with CRAO who gained HBOT. In addition to obtaining 20 sessions of HBOT, oral acetazolamide and topical beta-blockers were being administered to the patients at the earliest probable time.“Dr. Weber and his staff were incre